AAAAAA

   
Results: 1-18 |
Results: 18
Characterization of Forssman and other antigen/antibody systems in vascularized mouse heart to rat xenotransplantation
Authors: Gustavsson, ML Johnsson, C Albertsson, P Lukes, D Steen, LM Johansson, BR Mjornstedt, L Norrby, J Tufveson, G Olausson, M
Citation: Ml. Gustavsson et al., Characterization of Forssman and other antigen/antibody systems in vascularized mouse heart to rat xenotransplantation, SC J IMMUN, 53(2), 2001, pp. 121-131
Hyaluronidase reduces intragraft pressure of rejecting tissue
Authors: Johnsson, C Hallgren, R Tufveson, G
Citation: C. Johnsson et al., Hyaluronidase reduces intragraft pressure of rejecting tissue, TRANSPLAN P, 33(4), 2001, pp. 2484-2484
Organ donation, allocation, and transplantation in the Nordic countries: Scandiatransplant 1999
Authors: Grunnet, N Asmundsson, P Bentdal, O Madsen, M Persson, NH Salmela, K Tufveson, G
Citation: N. Grunnet et al., Organ donation, allocation, and transplantation in the Nordic countries: Scandiatransplant 1999, TRANSPLAN P, 33(4), 2001, pp. 2505-2510
Procurement of human pancreases for islet isolation - The initiation of a Scandianvian collaborative network
Authors: Rydgard, KJ Song, Z Foss, A Ostraat, O Tufveson, G Wennberg, L Lundgren, T Tibell, A Groth, CG Korsgren, Q
Citation: Kj. Rydgard et al., Procurement of human pancreases for islet isolation - The initiation of a Scandianvian collaborative network, TRANSPLAN P, 33(4), 2001, pp. 2538-2538
Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis
Authors: Ekberg, H Backman, L Tufveson, G Tyden, G Nashan, B Vincenti, F
Citation: H. Ekberg et al., Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis, TRANSPLAN I, 13(2), 2000, pp. 151-159
Concordant xenotransplantation - non-vascularized pancreatic islets are more difficult to regraft than the vascularized heart
Authors: Bersztel, A Andersson, A Bjorkland, A Tufveson, G Johnsson, C
Citation: A. Bersztel et al., Concordant xenotransplantation - non-vascularized pancreatic islets are more difficult to regraft than the vascularized heart, XENOTRANSPL, 7(2), 2000, pp. 118-128
Chronic allograft dysfunction - Chronic rejection revisited
Authors: Tufveson, G Johnsson, C
Citation: G. Tufveson et C. Johnsson, Chronic allograft dysfunction - Chronic rejection revisited, TRANSPLANT, 70(3), 2000, pp. 411-412
Monitoring of intragraft pressure of rejecting organs - Increased tissue pressure can be reduced by hyaluronidase therapy
Authors: Johnsson, C Tufveson, G Hallgren, R
Citation: C. Johnsson et al., Monitoring of intragraft pressure of rejecting organs - Increased tissue pressure can be reduced by hyaluronidase therapy, TRANSPLANT, 70(11), 2000, pp. 1575-1580
Role of hyaluronan in acute pancreatitis
Authors: Johnsson, C Hallgren, R Tufveson, G
Citation: C. Johnsson et al., Role of hyaluronan in acute pancreatitis, SURGERY, 127(6), 2000, pp. 650-658
Edema treatment during cardiac allograft rejection
Authors: Johnsson, C Hallgren, R Lindbom, LO Tufveson, G
Citation: C. Johnsson et al., Edema treatment during cardiac allograft rejection, J HEART LUN, 18(12), 1999, pp. 1238-1242
Ex vivo propagation and characterization of lymphocytes from rejecting rat-kidney allografts
Authors: Engstrand, M Johnsson, C Korsgren, O Tufveson, G
Citation: M. Engstrand et al., Ex vivo propagation and characterization of lymphocytes from rejecting rat-kidney allografts, TRANSPL IMM, 7(4), 1999, pp. 189-196
Hyaluronidase ameliorates rejection-induced edema
Authors: Johnsson, C Hallgren, R Elvin, A Gerdin, B Tufveson, G
Citation: C. Johnsson et al., Hyaluronidase ameliorates rejection-induced edema, TRANSPLAN I, 12(4), 1999, pp. 235-243
Tolerance or rejection: A delicate balance as judged by exposure of heart-transplanted rats to the immunomodulator Linomide (R)
Authors: Qi, Z Tufveson, G Ekberg, H
Citation: Z. Qi et al., Tolerance or rejection: A delicate balance as judged by exposure of heart-transplanted rats to the immunomodulator Linomide (R), SC J IMMUN, 50(4), 1999, pp. 394-398
Antithymocyte globulin and cyclosporin A are synergistic in an experimental transplantation tolerance model in the rat
Authors: Olausson, M Lukes, D Norrby, J Qi, Z Ekberg, H Gannedahl, G Tufveson, G Mjornstedt, L
Citation: M. Olausson et al., Antithymocyte globulin and cyclosporin A are synergistic in an experimental transplantation tolerance model in the rat, SC J IMMUN, 49(1), 1999, pp. 38-44
The relative influence of antigen-dependent and independent factors for development and progression of chronic rejection
Authors: Fellstrom, B Akuyrek, LM Backman, U Jonsson, C Larsson, E Tufveson, G Wahlberg, J
Citation: B. Fellstrom et al., The relative influence of antigen-dependent and independent factors for development and progression of chronic rejection, TRANSPLAN P, 31(7), 1999, pp. 2717-2718
Zenapax (daclizumab) reduces the incidence of acute rejection episodes andimproves patient survival following renal transplantation
Authors: Ekberg, H Backman, L Tufveson, G Tyden, G
Citation: H. Ekberg et al., Zenapax (daclizumab) reduces the incidence of acute rejection episodes andimproves patient survival following renal transplantation, TRANSPLAN P, 31(1-2), 1999, pp. 267-268
Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial
Authors: Behrend, M Grinyo, J Vanrenterghem, Y Rodicio, J Albrechtsen, D Sadek, S Soulillou, JP van Son, W Groth, C Mjornstedt, L Wiesel, M Neumayer, HH Tufveson, G Ekberg, H Tarantino, A Thiel, G Hene, R Morgan, A Wang, W Ramos, E Rees, M
Citation: M. Behrend et al., Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial, TRANSPLANT, 68(3), 1999, pp. 391-396
Methods in experimental xenogeneic transplantation state of the art
Authors: Hammer, C Tufveson, G
Citation: C. Hammer et G. Tufveson, Methods in experimental xenogeneic transplantation state of the art, ANIMAL MODELLING IN SURGICAL RESEARCH, 1998, pp. 239-247
Risultati: 1-18 |